The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Novel risk scoring system for metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (C).
 
Meredith R Kline
No Relationships to Disclose
 
Dylan J. Martini
No Relationships to Disclose
 
Yuan Liu
No Relationships to Disclose
 
Julie M. Shabto
No Relationships to Disclose
 
Bradley Curtis Carthon
No Relationships to Disclose
 
Elise Hitron
No Relationships to Disclose
 
Greta Russler
No Relationships to Disclose
 
Sarah Caulfield
No Relationships to Disclose
 
Lauren Beth Yantorni
No Relationships to Disclose
 
Wayne Harris
No Relationships to Disclose
 
Omer Kucuk
No Relationships to Disclose
 
Viraj A. Master
No Relationships to Disclose
 
Mehmet Asim Bilen
Consulting or Advisory Role - Eisai; EMD Serono; Exelixis; Genomic Health; Janssen; Nektar; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Incyte (Inst); Nektar (Inst); Peleton (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst); Xencor (Inst)